Early Screening and Treatment of Heart Complication in Sickle Cell Disease

Abroad (travel likely)RecruitingPHASE2

Conditions

Sickle Cell Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Inova Schar Cancer, Fairfax, Virginia, United States
Contact: Study coordinator (Keary Jane't) · keary.janet@inova.org · 571-472-3173
Contact: Principal Investigator (Sheinei Alan, MD)
Inova Health Care Service, Falls Church, Virginia, United States
Contact: Study coordinator (Keary Jane't) · keary.janet@inova.org · 571-472-3173
Contact: Study coordinator (Elahe Mollapour) · elahe.mollapour@inova.org · 571-472-0615
Contact: Principal Investigator (Sheinei Alan, MD)

Study leads

Sheinei Alan, MD
Principal Investigator
Inova Fairfax Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors

Sickle Cell Disease · Beta-thalassemia

Abroad (travel likely)RecruitingPHASE1, PHASE2

Bethesda, United States

A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary Stroke

Sickle Cell Disease

Abroad (travel likely)RecruitingPHASE2

Raipur, India · Delhi, India

AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion

Acute Leukemia · Severe Aplastic Anemia · Non-hodgkin Lymphoma

Abroad (travel likely)RecruitingPHASE2

Valhalla, United States

Investigation Into the Use of BAH243 Lentiviral Vector for Gene Therapy in Treating Sickle Cell Disease

Sickle Cell Disease · Sickle-Cell Disease With Crisis

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beijing, China